Matthew Hill

Company: Elegen

Job title: Chief Executive Officer

Seminars:

Unlock Next-Gen mRNA Therapy Development – Rapid, Cell-Free DNA Manufacturing 9:30 am

Cell-free DNA production offers a streamlined highly scalable workflow for mRNA therapy development Elimination of cell-based cloning enables researchers to evaluate a more diverse sequence space faster Bypassing pDNA with NGS-verified, complex, full-length linear IVT-ready DNA eliminates time and costs of establishing master cell banksRead more

day: Conference Day One